These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 2436827)

  • 1. Frequency- and orientation-dependent effects of mexiletine and quinidine on conduction in the intact dog heart.
    Bajaj AK; Kopelman HA; Wikswo JP; Cassidy F; Woosley RL; Roden DM
    Circulation; 1987 May; 75(5):1065-73. PubMed ID: 2436827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequency-dependent interactions of mexiletine and quinidine on depolarization and repolarization in canine Purkinje fibers.
    Roden DM; Iansmith DH; Woosley RL
    J Pharmacol Exp Ther; 1987 Dec; 243(3):1218-24. PubMed ID: 2447269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequency-dependent antiarrhythmic drug effects on postrepolarization refractoriness and ventricular conduction time in canine ventricular myocardium in vivo.
    Costard-Jäckle A; Franz MR
    J Pharmacol Exp Ther; 1989 Oct; 251(1):39-46. PubMed ID: 2795468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of sympathetic stimulation on use dependence of lidocaine, mexiletine, and quinidine in an intact canine model.
    Newman D; Herre JM; Chin M; Scheinman MM; Franz M; Katzung B
    Can J Physiol Pharmacol; 1992 Feb; 70(2):219-24. PubMed ID: 1325863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Electropharmacologic synergism with mexiletine and quinidine.
    Duff HJ; Kolodgie FD; Roden DM; Woosley RL
    J Cardiovasc Pharmacol; 1986; 8(4):840-6. PubMed ID: 2427827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequency-dependent effect of quinidine, mexiletine, and their combination on postrepolarization refractoriness in vivo.
    Costard-Jaeckle A; Liem LB; Franz MR
    J Cardiovasc Pharmacol; 1989 Dec; 14(6):810-7. PubMed ID: 2481766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of quinidine in the mexiletine-quinidine interaction: electrophysiologic correlates of enhanced antiarrhythmic efficacy.
    Duff HJ; Rahmberg M; Sheldon RS
    J Cardiovasc Pharmacol; 1990 Nov; 16(5):685-92. PubMed ID: 1703588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modification of the frequency- and voltage-dependent effects of quinidine when administered in combination with tocainide in canine Purkinje fibers.
    Valois M; Sasyniuk BI
    Circulation; 1987 Aug; 76(2):427-41. PubMed ID: 2440617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequency-dependent effects of quinidine on the ventricular action potential and QRS duration in humans.
    Nademanee K; Stevenson WG; Weiss JN; Frame VB; Antimisiaris MG; Suithichaiyakul T; Pruitt CM
    Circulation; 1990 Mar; 81(3):790-6. PubMed ID: 2306831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mexiletine-quinidine in isolated hearts: an interaction involving the sodium channel.
    Duff HJ; Cannon NJ; Sheldon RS
    Cardiovasc Res; 1989 Jul; 23(7):584-92. PubMed ID: 2557155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conduction velocity depression and drug-induced ventricular tachyarrhythmias. Effects of lidocaine in the intact canine heart.
    Anderson KP; Walker R; Lux RL; Ershler PR; Menlove R; Williams MR; Krall R; Moddrelle D
    Circulation; 1990 Mar; 81(3):1024-38. PubMed ID: 2155070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacologic conversion and suppression of experimental canine atrial flutter: differing effects of d-sotalol, quinidine, and lidocaine and significance of changes in refractoriness and conduction.
    Feld GK; Venkatesh N; Singh BN
    Circulation; 1986 Jul; 74(1):197-204. PubMed ID: 3708774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of simultaneous administration of mexiletine and quinidine on the electrophysiologic parameters of canine Purkinje fibers.
    Burke GH; Loukides JE; Berman ND
    J Cardiovasc Pharmacol; 1986; 8(6):1138-43. PubMed ID: 2434738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between use-dependent effects of antiarrhythmic drugs on conduction and Vmax in canine cardiac Purkinje fibers.
    Nattel S
    J Pharmacol Exp Ther; 1987 Apr; 241(1):282-8. PubMed ID: 3572790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Translation of flecainide- and mexiletine-induced cardiac sodium channel inhibition and ventricular conduction slowing from nonclinical models to clinical.
    Heath BM; Cui Y; Worton S; Lawton B; Ward G; Ballini E; Doe CP; Ellis C; Patel BA; McMahon NC
    J Pharmacol Toxicol Methods; 2011; 63(3):258-68. PubMed ID: 21194571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of halothane and quinidine on intracardiac conduction and QTc interval in pentobarbital-anesthetized dogs.
    Gallagher JD
    Anesth Analg; 1992 Nov; 75(5):688-95. PubMed ID: 1416119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Electrophysiological effects of mexiletine in man.
    Roos JC; Paalman AC; Dunning AJ
    Br Heart J; 1976 Dec; 38(12):1262-71. PubMed ID: 1008969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electrocardiographic interactions between pinacidil, a potassium channel opener and class I antiarrhythmic agents in guinea-pig isolated perfused heart.
    Yang Q; Padrini R; Bova S; Piovan D; Magnolfi G
    Br J Pharmacol; 1995 Apr; 114(8):1745-9. PubMed ID: 7599944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mexiletine and quinidine in combination in an ischemic model: supra-additive antiarrhythmic and electrophysiologic actions.
    Duff HJ; Gault NJ
    J Cardiovasc Pharmacol; 1986; 8(4):847-57. PubMed ID: 2427828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mexiletine-quinidine combination: enhanced antiarrhythmic and electrophysiologic activity in the dog.
    Duff HJ
    J Pharmacol Exp Ther; 1989 May; 249(2):617-22. PubMed ID: 2724143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.